Biologics/Immunotherapy News

Oral immunotherapy for peanut allergy was safe and effective for infants, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Children with asthma aged 6 years to younger than 12 years had similar reductions in exacerbations with omalizumab regardless of race, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

PARK CITY, Utah — Bee stings and a good night’s rest were on the agenda, among other topics, during the second day of the Association of PAs in Allergy, Asthma and Immunology Annual Allergy, Asthma & Immunology CME Conference.

Mepolizumab, reslizumab and dupilumab were equally effective in controlling symptoms among patients with eosinophilic severe asthma, according to a study published in Annals of Allergy, Asthma & Immunology.

Sublingual immunotherapy for house dust mite allergic asthma improved bronchial epithelial antiviral resistance to viral infection, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

Tezepelumab reduced health care utilization for asthma across all outcomes measured, as well as the severity of exacerbations that required hospitalizations, according to a study published in Annals of Allergy, Asthma & Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in June.

Dupilumab improved outcomes among patients with severe chronic rhinosinusitis with nasal polyps across a range of type 2 inflammatory signatures, according to data presented at EAACI Hybrid Congress 2023 in Hamburg, Germany.

Subcutaneous immunotherapy for house dust mite allergy may slightly protect patients against SARS-CoV-2 infection, especially after the dose-escalation phase, according to a letter published in Clinical and Translational Allergy.

Patients on oral immunotherapy for food allergy were satisfied with a 24/7 telephone helpline that provided support for their treatment, according to a letter published in Clinical and Translational Allergy.